| Rachael Free Earnest, MD | |
|
3140 Legacy Dr Ste 110, Frisco, TX 75034-7918 | |
| (972) 469-2626 | |
| (972) 469-2818 |
| Full Name | Rachael Free Earnest |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 9 Years |
| Location | 3140 Legacy Dr Ste 110, Frisco, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306230537 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | S1391 (Texas) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Epiphany Dermatology Pa | 3971827791 | 69 |
News Archive
Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.
Republican primary candidates are caught in an Obamacare fix. Even the slightest hint that a GOP contender might support anything besides all-out repeal of the health care law is drawing attacks from the right. So, increasingly, in races across the country, proposals to fix the existing law or retain any of it are being ruled out by Republicans eager to further burnish their conservative credentials (Hohmann and Cheney, 12/15).
A feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment will be conducted at Wake Forest University Baptist Medical Center. This will be part of the first significant study of the medical device in the United States.
General Nutrition Centers, Inc., a leading global specialty retailer of nutritional products, today reported its financial results for the quarter ended June 30, 2010.
› Verified 6 days ago
| Entity Name | Epiphany Dermatology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043615263 PECOS PAC ID: 3971827791 Enrollment ID: O20150126001498 |
News Archive
Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.
Republican primary candidates are caught in an Obamacare fix. Even the slightest hint that a GOP contender might support anything besides all-out repeal of the health care law is drawing attacks from the right. So, increasingly, in races across the country, proposals to fix the existing law or retain any of it are being ruled out by Republicans eager to further burnish their conservative credentials (Hohmann and Cheney, 12/15).
A feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment will be conducted at Wake Forest University Baptist Medical Center. This will be part of the first significant study of the medical device in the United States.
General Nutrition Centers, Inc., a leading global specialty retailer of nutritional products, today reported its financial results for the quarter ended June 30, 2010.
› Verified 6 days ago
| Entity Name | Legacy Dermatology ,pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134588148 PECOS PAC ID: 9032492822 Enrollment ID: O20170329000271 |
News Archive
Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.
Republican primary candidates are caught in an Obamacare fix. Even the slightest hint that a GOP contender might support anything besides all-out repeal of the health care law is drawing attacks from the right. So, increasingly, in races across the country, proposals to fix the existing law or retain any of it are being ruled out by Republicans eager to further burnish their conservative credentials (Hohmann and Cheney, 12/15).
A feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment will be conducted at Wake Forest University Baptist Medical Center. This will be part of the first significant study of the medical device in the United States.
General Nutrition Centers, Inc., a leading global specialty retailer of nutritional products, today reported its financial results for the quarter ended June 30, 2010.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachael Free Earnest, MD 507 Hunters Run, Bossier City, LA 71111-8171 Ph: () - | Rachael Free Earnest, MD 3140 Legacy Dr Ste 110, Frisco, TX 75034-7918 Ph: (972) 469-2626 |
News Archive
Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.
Republican primary candidates are caught in an Obamacare fix. Even the slightest hint that a GOP contender might support anything besides all-out repeal of the health care law is drawing attacks from the right. So, increasingly, in races across the country, proposals to fix the existing law or retain any of it are being ruled out by Republicans eager to further burnish their conservative credentials (Hohmann and Cheney, 12/15).
A feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment will be conducted at Wake Forest University Baptist Medical Center. This will be part of the first significant study of the medical device in the United States.
General Nutrition Centers, Inc., a leading global specialty retailer of nutritional products, today reported its financial results for the quarter ended June 30, 2010.
› Verified 6 days ago
Dr. Amanda Hope Champlain, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4685 Eldorado Pkwy Ste 100, Frisco, TX 75033 Phone: 972-335-2727 Fax: 972-668-8444 | |
Dr. Carla Gustovich, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13192 Dallas Pkwy Ste 620, Frisco, TX 75033 Phone: 972-668-3376 Fax: 972-668-7546 | |
Rachel Heather Quinby-graves, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13192 Dallas Pkwy Ste 620, Frisco, TX 75033 Phone: 972-668-3376 Fax: 972-668-7546 | |
Dr. Lucy Li, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9191 Kyser Way Bldg 3 Ste B, Frisco, TX 75034 Phone: 972-712-3131 Fax: 972-712-7171 | |
Dr. Timothy Rodgers, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3880 Parkwood Blvd, Suite 102, Frisco, TX 75034 Phone: 972-704-2400 | |
Dr. Jennifer Warner Dharamsi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3140 Legacy Drive, Suite 110, Frisco, TX 75034 Phone: 972-469-2626 Fax: 972-469-2818 |